I am a physician-scientist who works as part of a multidisciplinary group treating patients with breast cancer.
I also have broad interests in cancer biology. My research is focused on understanding how proteins called growth or inflammatory factors promote tumor growth and metastatic progression (when tumors spread to other sites in the body). Specifically, I study how these factors mediate the cross-talk between tumor cells and cells comprising the “tumor micro-environment.” We hypothesize that it is the tumor’s “milieu” or setting that determines the aggressiveness of cancers.
We are developing therapies targeted to these inflammatory pathways, which we believe will alter the behavior of cancers, making them sensitive to chemotherapies and hormonal therapies, and incapable of metastasizing. Our preclinical research is demonstrating that these approaches are applicable not only to breast cancer but to a number of other cancers including prostate, lung, ovarian, liver, and colorectal cancers. For further information about my research activities please see the link below.
- Clinical Expertise: Breast Cancer
- Languages Spoken: English
- Education: MD, PhD, The University of North Carolina at Chapel Hill
- Residencies: Barnes Hospital (St. Louis)
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Internal Medicine; Medical Oncology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more